Medical trial helps paralysed Bedfordshire woman be a mum again
Mrs Wilson broke her neck when she was thrown off a horse which was spooked by a pheasant, on her family farm in 2018.The 39-year-old, from Houghton Conquest, near Bedford, severed her spinal cord in the small gap between her helmet and the top of her body protector, leaving her paralysed from the chest down.Unable to reach her phone, she lay on the ground until a friend's three-year-old daughter found her."For me it was like instant paralysis," she said. "I just couldn't feel anything".She was taken to Addenbrooke's Hospital in Cambridgeshire and when she woke from a coma, the only part of her body she could move was her head.
Mrs Wilson took part in the year-long-trial which involved stimulating her spinal cord with electrical pulses with a device called ARC-EX.The pulses excited neurons so that signals weakened or interrupted by injury, could drive movement. Following the trial, she could perform tasks on her farm as well as use a computer, which she said had made a huge difference to her independence and confidence."It was really life changing," she said.
'I just feel like mum now'
Mrs Wilson described how she could now be an active parent again."Just to be able to use my arms so I can cook with them, we can bake together, I can pass them things in the bath. "It sounds trivial but those things really make a difference.""I obviously wanted to be the best mum I could be, but felt utterly useless at times, but I don't remember the last time I felt like that because I just feel like 'mum' now. It's really exciting for the future."The research, which involved 10 participants, has been published in the peer reviewed journal "Neuromodulation: Technology at Neural Interface".
Other trial participants saw improvements in their balance and lower body functions.The study follows research focussed on upper body strength which was published in 2024 in the journal "Nature Medicine" which saw positive results.This latest Pathfinder2 trial was funded by the Spinal Research charity and looked at different part of the body.Chair Tara Stewart said: "This therapy is not a silver bullet. It works on spared spinal tissue so results will vary widely, and it does need to be paired with proper active rehabilitation."Even so, this is a game changing moment. It's now time to stop talking about spinal cord injury as being incurable and to stop telling people with this injury that nothing can be done."
The study concluded that a larger scale trial would be beneficial. It also said the absence of a control made it difficult to establish how much progress was down to rehabilitation exercises and how much could be attributed to spinal stimulation.Spinal Research is funding three other UK studies involving use of implantable and external spinal cord stimulation systems."With proper investment in the spinal research field we could see significant progress towards a cure for paralysis in the next five to seven years," said Ms Stewart.
Follow Beds, Herts and Bucks news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scotsman
an hour ago
- Scotsman
UK pharmacists back weight loss jabs - and say it's nothing to be ashamed of
It comes as obesity affects over 1 in 4 adults in the UK | Shutterstock Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss treatments as a quarter of Brits battle obesity. Sign up to our daily newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Happy Pharmacy, an online UK-based pharmacy, is urging the media, healthcare providers, and the public to help dismantle the stigma around prescription weight loss injections. It comes as obesity affects over 1 in 4 adults in the UK - and more people are turning to medically approved treatments to support weight loss under professional supervision. Recent advances in weight loss injections, including Mounjaro® (tirzepatide) and Wegovy® (semaglutide) are shifting perceptions and offering new hope to individuals struggling with weight-related health issues. Palvinder Deol, Superintendent Pharmacist at Happy Pharmacy , said: 'Medications like Mounjaro and Wegovy give people the opportunity to take control of their health in a safe, evidence-based way. 'Obesity is a complex condition involving more than just diet and people deserve support, not judgment, when seeking help.' According to guidance from the National Institute for Health and Care Excellence (NICE) patients with a BMI of 35 or above, or 30+ with weight-related complications, such as high blood pressure or joint problems, may be eligible for these medications as confirmed by NHS England. 'We need to reframe weight loss support as a legitimate medical need,' Palvinder adds. 'When treatments are clinically indicated, patients should feel confident in pursuing them just as they would for any other health condition.' Both medications must be prescribed by a qualified healthcare professional following a full clinical assessment. They are not suitable for everyone, and are only offered to individuals who meet the eligibility criteria outlined by NICE and the MHRA. Following their regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA) in late 2023, these treatments are being increasingly prescribed as part of structured weight management programmes across the country. Patients with a BMI of 35 or above, or 30+ with weight-related complications, may be eligible for these medications as confirmed by NHS England | Shutterstock 'We need to reframe weight loss support as a legitimate medical need' Happy Pharmacy, which launched in March 2025, provides a holistic online service offering treatments for weight loss, hair loss, and erectile dysfunction through pharmacist-led consultations. The goal of treatment is not cosmetic enhancement but to reduce long-term risks associated with conditions such as type 2 diabetes, cardiovascular disease, and obstructive sleep apnoea. Despite this clinical backing, Happy Pharmacy reports that many patients hesitate to pursue treatment due to lingering stigma and misinformation about obesity and medical intervention. Despite clinical studies supporting the efficacy of these medications. In a 72-week trial , Mounjaro users lost an average of 20% of their body weight. While participants prescribed Wegovy experienced a 15% reduction in body weight during the same timeframe. Observational data also suggests these treatments may deliver broader health benefits, including lowered risks of stroke and dementia in patients with type 2 diabetes. Beyond health improvements, weight loss injections may also offer economic relief. According to Happy Pharmacy's internal Food Savings Calculator , patients using appetite-suppressing medications could save up to £300 per month on food costs, depending on previous eating patterns. About Happy Pharmacy Happy Pharmacy is a UK-registered and fully regulated online pharmacy with over 10 years of experience in safely dispensing prescription medications nationwide. The service offers convenient access to licensed treatments following consultation with a healthcare professional. Palvinder Deol, BPharm (Hons), is a GPhC‑registered pharmacist with over 25 years of experience. His clinical and educational expertise spans pharmacy practice, weight loss medicines, and patient care. He currently serves as Superintendent Pharmacist ( Happy Pharmacy ).
Glasgow Times
8 hours ago
- Glasgow Times
Officials urge those who left school without lifesaving vaccine to get protected
It comes amid warnings that more than 418,000 children have left school with no protection against human papillomavirus (HPV) in the last three years. The HPV vaccine is offered to boys and girls when they are in Year 8 and is key to wiping out cervical cancer in the UK. Around 13 high-risk types of HPV are known to cause 99.7% of cervical cancers. The jab also protects against genital warts and head and neck cancers, such as those in the mouth or throat. Now, GP practices in England will invite 16 to 25-year-olds to have the vaccine if records show they did not have it in school. According to NHS England, more than 418,000 children left school without having the jab in the last three years, with concerns there are many more people aged 16 to 25 who are not protected. Dr Amanda Doyle, national director of primary care and community services, said: 'This vaccine is hugely important in our fight to eradicate cervical cancer but it isn't just for girls and women – it's also vital for boys and men to get vaccinated to protect themselves against cancers of the mouth, throat or genitals, while preventing spreading the HPV infection to sexual partners who could then develop cervical cancer. 'Too many lives are lost to cervical cancer so the hard work of NHS staff across the country in vaccinating and screening as many people as possible will help us to meet our ambition of wiping out this disease. 'Encouraging progress has been made recently in increasing uptake but we know there is much more to do. 'So if you're eligible for a HPV vaccination or are the parent of a child who is eligible, but didn't get the vaccine at school when they had the chance, I would urge you to come forward when your GP contacts you. 'Only a single dose is required and it could save you or your child's life.' Data shows that in the 2023/24 academic year, some 76.7% of girls and 71.2% of boys aged 14 to 15 were vaccinated against HPV by Year 10. Uptake in Year 8 increased to 72.9% among girls and 67.7% among boys, from 71.3% and 65.2% respectively a year earlier. The health service will aim to boost uptake among girls to 90% as part of plans to eliminate cervical cancer by 2040. It will also aim to increase the number of women attending cervical cancer screening appointments. Public health minister Ashley Dalton said the vaccine 'is our most powerful tool in our fight to eliminate cervical cancer by 2040' but said there is a 'long way to go'. 'Thousands of young people are still unvaccinated and vulnerable to this disease – which is so easily prevented,' she added. Last month, the UK Health Security Agency (UKHSA) warned young women in some parts of England are at greater risk of cervical cancer because not enough children are getting the jab. Analysis by the agency showed inequalities in vaccine uptake in some regions – by Year 10, HPV coverage in girls was lowest in London (64.9%) and highest in the South East (82.7%). Among boys, it was also lowest in London (58.9%) and highest in the South East (77.3%). Meanwhile, at local authority level, Year 10 vaccination levels in girls ranged from 38.7% (Lambeth in London) to 97.6% (Northumberland). Among boys, it ranged from 28.2% (Lambeth in London) to 92.2% (West Berkshire). Dr Sharif Ismail, consultant epidemiologist at UKHSA, said: 'We know that uptake of the HPV vaccination in young people has fallen significantly since the pandemic, leaving many, many thousands across the country at greater risk of HPV-related cancers. 'This is a real concern as each HPV vaccine, now just a single dose offered in schools, gives a young person good protection against the devastating impact of these cancers, which includes cervical, genital, mouth and throat cancers. 'This new catch-up campaign is a really important opportunity for us to make sure that no teenage girl or boy, young woman or man is denied that protection.'
Leader Live
10 hours ago
- Leader Live
Officials urge those who left school without lifesaving vaccine to get protected
It comes amid warnings that more than 418,000 children have left school with no protection against human papillomavirus (HPV) in the last three years. The HPV vaccine is offered to boys and girls when they are in Year 8 and is key to wiping out cervical cancer in the UK. Around 13 high-risk types of HPV are known to cause 99.7% of cervical cancers. The jab also protects against genital warts and head and neck cancers, such as those in the mouth or throat. Now, GP practices in England will invite 16 to 25-year-olds to have the vaccine if records show they did not have it in school. According to NHS England, more than 418,000 children left school without having the jab in the last three years, with concerns there are many more people aged 16 to 25 who are not protected. Dr Amanda Doyle, national director of primary care and community services, said: 'This vaccine is hugely important in our fight to eradicate cervical cancer but it isn't just for girls and women – it's also vital for boys and men to get vaccinated to protect themselves against cancers of the mouth, throat or genitals, while preventing spreading the HPV infection to sexual partners who could then develop cervical cancer. 'Too many lives are lost to cervical cancer so the hard work of NHS staff across the country in vaccinating and screening as many people as possible will help us to meet our ambition of wiping out this disease. 'Encouraging progress has been made recently in increasing uptake but we know there is much more to do. 'So if you're eligible for a HPV vaccination or are the parent of a child who is eligible, but didn't get the vaccine at school when they had the chance, I would urge you to come forward when your GP contacts you. 'Only a single dose is required and it could save you or your child's life.' Data shows that in the 2023/24 academic year, some 76.7% of girls and 71.2% of boys aged 14 to 15 were vaccinated against HPV by Year 10. Uptake in Year 8 increased to 72.9% among girls and 67.7% among boys, from 71.3% and 65.2% respectively a year earlier. The health service will aim to boost uptake among girls to 90% as part of plans to eliminate cervical cancer by 2040. It will also aim to increase the number of women attending cervical cancer screening appointments. Public health minister Ashley Dalton said the vaccine 'is our most powerful tool in our fight to eliminate cervical cancer by 2040' but said there is a 'long way to go'. 'Thousands of young people are still unvaccinated and vulnerable to this disease – which is so easily prevented,' she added. Last month, the UK Health Security Agency (UKHSA) warned young women in some parts of England are at greater risk of cervical cancer because not enough children are getting the jab. Analysis by the agency showed inequalities in vaccine uptake in some regions – by Year 10, HPV coverage in girls was lowest in London (64.9%) and highest in the South East (82.7%). Among boys, it was also lowest in London (58.9%) and highest in the South East (77.3%). Meanwhile, at local authority level, Year 10 vaccination levels in girls ranged from 38.7% (Lambeth in London) to 97.6% (Northumberland). Among boys, it ranged from 28.2% (Lambeth in London) to 92.2% (West Berkshire). Dr Sharif Ismail, consultant epidemiologist at UKHSA, said: 'We know that uptake of the HPV vaccination in young people has fallen significantly since the pandemic, leaving many, many thousands across the country at greater risk of HPV-related cancers. 'This is a real concern as each HPV vaccine, now just a single dose offered in schools, gives a young person good protection against the devastating impact of these cancers, which includes cervical, genital, mouth and throat cancers. 'This new catch-up campaign is a really important opportunity for us to make sure that no teenage girl or boy, young woman or man is denied that protection.'
